How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Probabilistic models, such as hidden Markov models or Bayesian networks, are commonly used to model biological data. Much of their popularity can be attributed to the existence of efficient and robust ...

Machine learning is the ability of a machine to improve its performance based on previous results. Machine learning methods enable computers to learn without being explicitly programmed and have ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctt1pwt9w5.4 https ...

INTRODUCTION: Using an App to Go to Work—Uber as a Symbol of the New Economy INTRODUCTION: Using an App to Go to Work—Uber as a Symbol of the New Economy (pp. 1 ...

How machine intelligence changes the rules of business by Marco Iansiti and Karim R. Lakhani In 2019, just five years after the Ant Financial Services Group was launched, the number of consumers using ...